Cargando…

ERα36-High Cancer-Associated Fibroblasts as an Unfavorable Factor in Triple-Negative Breast Cancer

SIMPLE SUMMARY: The tumor microenvironment, as an important constituent of neoplastic tissue, has been a promising target for cancer therapy. Triple-negative breast cancer accounts for around 10–20% of invasive breast cancers. This study describes a new cancer-associated fibroblast subtype character...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagel, Anna, Popeda, Marta, Muchlinska, Anna, Sadej, Rafal, Szade, Jolanta, Zielinski, Jacek, Skokowski, Jaroslaw, Niemira, Magdalena, Kretowski, Adam, Markiewicz, Aleksandra, Zaczek, Anna J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024776/ https://www.ncbi.nlm.nih.gov/pubmed/35454913 http://dx.doi.org/10.3390/cancers14082005

Ejemplares similares

Alpha-smooth muscle actin-positive cancer-associated fibroblasts secreting osteopontin promote growth of luminal breast cancer
por: Muchlińska, Anna, et al.
Publicado: (2022)

Clinical and Biological Significance of ESR1 Gene Alteration and Estrogen Receptors Isoforms Expression in Breast Cancer Patients
por: Nagel, Anna, et al.
Publicado: (2019)

Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients
por: Popeda, Marta, et al.
Publicado: (2021)

NF-kappa B Signaling-Related Signatures Are Connected with the Mesenchymal Phenotype of Circulating Tumor Cells in Non-Metastatic Breast Cancer
por: Popeda, Marta, et al.
Publicado: (2019)

Prognostic Significance of ESR1 Amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 Polymorphisms in Breast Cancer Patients
por: Markiewicz, Aleksandra, et al.
Publicado: (2013)

Aggressive Phenotype of Cells Disseminated via Hematogenous and Lymphatic Route in Breast Cancer Patients
por: Markiewicz, Aleksandra, et al.
Publicado: (2018)

Heterogeneity of Mesenchymal Markers Expression—Molecular Profiles of Cancer Cells Disseminated by Lymphatic and Hematogenous Routes in Breast Cancer
por: Markiewicz, Aleksandra, et al.
Publicado: (2013)

Mesenchymal Phenotype of CTC-Enriched Blood Fraction and Lymph Node Metastasis Formation Potential
por: Markiewicz, Aleksandra, et al.
Publicado: (2014)

Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
por: Markiewicz, Aleksandra, et al.
Publicado: (2012)

Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients
por: Markiewicz, Aleksandra, et al.
Publicado: (2019)

Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression
por: Nastały, Paulina, et al.
Publicado: (2021)

Improved Characterization of Circulating Tumor Cells and Cancer-Associated Fibroblasts in One-Tube Assay in Breast Cancer Patients Using Imaging Flow Cytometry
por: Muchlińska, Anna, et al.
Publicado: (2023)

Novel Approaches in Ovarian Cancer Research against Heterogeneity, Late Diagnosis, Drug Resistance, and Transcoelomic Metastases
por: Erol, Anna, et al.
Publicado: (2019)

microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study
por: Kunc, Michał, et al.
Publicado: (2020)

Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression
por: Bednarz-Knoll, Natalia, et al.
Publicado: (2015)

Detection and Characterization of Circulating Tumor Cells Using Imaging Flow Cytometry—A Perspective Study
por: Muchlińska, Anna, et al.
Publicado: (2022)

FGFR2 Controls Growth, Adhesion and Migration of Nontumorigenic Human Mammary Epithelial Cells by Regulation of Integrin β1 Degradation
por: Mieczkowski, Kamil, et al.
Publicado: (2023)

Interactions between FGFR2 and RSK2—implications for breast cancer prognosis
por: Czaplinska, Dominika, et al.
Publicado: (2016)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
por: Bastiaansen, Anna E. M., et al.
Publicado: (2020)

Combined Assessment of Immune Checkpoint Regulator VISTA on Tumor-Associated Immune Cells and Platelet-to-Lymphocyte Ratio Identifies Advanced Germ Cell Tumors with Higher Risk of Unfavorable Outcomes
por: Pęksa, Rafał, et al.
Publicado: (2021)

The Role of Androgen Receptor and microRNA Interactions in Androgen-Dependent Diseases
por: Bielska, Agnieszka, et al.
Publicado: (2022)

Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA)
por: Niemira, Magdalena, et al.
Publicado: (2019)

Breast cancer circulating tumor cells with mesenchymal features—an unreachable target?
por: Topa, Justyna, et al.
Publicado: (2022)

Low Numbers of Vascular Vessels Correlate to Progression in Hormone-Naïve Prostate Carcinomas Undergoing Radical Prostatectomy
por: Smentoch, Julia, et al.
Publicado: (2019)

Insulin Resistance and Endometrial Cancer: Emerging Role for microRNA
por: Sidorkiewicz, Iwona, et al.
Publicado: (2020)

Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer
por: Niemira, Magdalena, et al.
Publicado: (2023)

MicroRNAs in regulation of triple-negative breast cancer progression
por: Piasecka, Dominika, et al.
Publicado: (2018)

Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients
por: Raczkowska, Justyna, et al.
Publicado: (2023)

Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells
por: Piasecka, Dominika, et al.
Publicado: (2016)

Cytocompatibility of stabilized black phosphorus nanosheets tailored by directly conjugated polymeric micelles for human breast cancer therapy
por: Biedulska, M., et al.
Publicado: (2021)

Identification and subsequent validation of transcriptomic signature associated with metabolic status in endometrial cancer
por: Sidorkiewicz, Iwona, et al.
Publicado: (2023)

FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer
por: Mieczkowski, Kamil, et al.
Publicado: (2022)

Huaier polysaccharide inhibits the stem-like characteristics of ERα-36(high) triple negative breast cancer cells via inactivation of the ERα-36 signaling pathway
por: Hu, Baoquan, et al.
Publicado: (2019)

The impact of the Polish mass breast cancer screening program on prognosis in the Pomeranian Province
por: Woźniacki, Piotr, et al.
Publicado: (2016)

Prognostic relevance of demographics and surgical practice for patients with gastric cancer in two centers: in Poland versus Germany
por: Jaworski, Radoslaw, et al.
Publicado: (2011)

Profiling of Invasive Breast Carcinoma Circulating Tumour Cells—Are We Ready for the ‘Liquid’ Revolution?
por: Braun, Marcin, et al.
Publicado: (2019)

Recent Highlights of Research on miRNAs as Early Potential Biomarkers for Cardiovascular Complications of Type 2 Diabetes Mellitus
por: Bielska, Agnieszka, et al.
Publicado: (2021)

Anethole prevents hydrogen peroxide-induced apoptosis and collagen metabolism alterations in human skin fibroblasts
por: Galicka, Anna, et al.
Publicado: (2014)

Expression Profile and Diagnostic Significance of MicroRNAs in Papillary Thyroid Cancer
por: Rogucki, Mariusz, et al.
Publicado: (2022)

The relationship between HER2 overexpression and angiogenesis in gastric cancer
por: Ciesielski, Maciej, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_629b3g41ov65o2u4d1cllfvhc4